Pratik Shah

Co-Founder at Design Therapeutics

Pratik Shah

Pratik Shah

Co-Founder at Design Therapeutics

Overview
Career Highlights

Auspex Pharmaceuticals, Inc.
Design Therapeutics
Altair Therapeutics, Inc.

RelSci Relationships

208

Number of Boards

11

Birthday

1969

Age

51

Contact Data
Trying to get in touch with Pratik Shah? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Pratik Shah likely has professional access to. A relationship does not necessarily indicate a personal connection.

Managing Director, H.I.G. Biohealth Partners at H.I.G. Capital LLC

Relationship likelihood: Strong

General Partner at Canaan Management, Inc.

Relationship likelihood: Strong

Executive Partner, Private Equity at Sofinnova Ventures, Inc.

Relationship likelihood: Strong

Co-Founder at Auspex Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Medical Officer at Protagonist Therapeutics, Inc.

Relationship likelihood: Strong

Co-Founder at Panorama Capital LLC

Relationship likelihood: Strong

Former Chief Financial Officer at Biogen, Inc.

Relationship likelihood: Strong

Vice President & Deputy General Counsel-Transactions at Teva Pharmaceutical Industries Ltd.

Relationship likelihood: Strong

Executive Vice President, General Counsel & Secretary at ACADIA Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman at Ascenta Therapeutics, Inc.

Relationship likelihood: Strong

Paths to Pratik Shah
Potential Connections via
Relationship Science
You
Pratik Shah
Co-Founder at Design Therapeutics
Education
PhD in Biochemistry & Molecular Biology

UCE’s Office of Investments is responsible for managing the University's investment assets, which includes overseeing the endowment to ensure that it benefits both current and future generations of the University of Chicago. They oversee the broad investment strategy and provide input to the development of the strategic and tactical investment policies of the University & UCMC endowments, pension plans and self-insurance trust assets. Their strategy combines qualitative and quantitative analysis, seeking to achieve superior investment performance on a risk-adjusted basis.

B.S. in Biological Sciences

University of California, Irvine is a public research university located in Irvine, California and one of the 10 general campuses in the University of California (UC) system. UCI's Orange County campus is the fifth-largest in the UC system. UC Irvine is considered a Public Ivy and became a member of the Association of American Universities in 1996, and is the youngest university to hold membership. It also administers the UC Irvine Medical Center, a large teaching hospital; the UC Irvine Health Sciences system in the City of Orange; the University of California, Irvine, Arboretum; and a portion of the University of California Natural Reserve System.

MBA

The University of Chicago Booth School of Business is a graduate business school located in Chicago, Illinois, at the University of Chicago. Formerly known as the University of Chicago Graduate School of Business, Chicago Booth is the second-oldest business school in the U.S., the first such school to offer an Executive MBA program, and the first to initiate a Ph.D. program in business. The school was renamed in 2008 following a $300 million endowment gift to the school by alumnus David G. Booth. The school has the third-largest endowment of any business school. The school's flagship campus is located in the Hyde Park neighborhood of Chicago on the main campus of the university. The school also maintains additional campuses in London and Asia (originally Singapore, but in July 2013 a move to Hong Kong was announced), as well as in downtown Chicago on the Magnificent Mile. In addition to conducting graduate business programs, the school conducts research in the fields of finance, economics, quantitative marketing research, and accounting. Chicago Booth is currently ranked first in the United States by Bloomberg Businessweek and first globally by the Economist.

Career History
Co-Founder
2017 - Current

Design Therapeutics, Inc. operates biotechnology company that develops therapies for serious degenerative disorders. The company was founded by Pratik Shah and Aseem Ansari and is headquartered in Solana Beach, CA.

President & Co-Chief Executive Officer
2007 - 2015

Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.

Boards & Committees
Chairman, Board of Directors
2007 - 2011

Altair is a privately owned company that was spun out of ISIS Pharmaceuticals in October 2007 with the objective of applying ISIS’s proprietary second generation (2’-MOE Gapmer) antisense oligoneucleotide technology to the field of inhaled therapeutics. Through its collaboration with ISIS Altair has access to both near term clinical stage opportunities, as well as early stage development projects.Altair's first compound AIR645 is currently in phase I clinical trials. This first in class compound posses unique anti-inflammatory activities appropriate for multiple therapeutic applications, including asthma, rhinitis and COPD. Additionally, the characteristics of the 2'-MOE Gapmer chemistry provides for the possibility of administration of AIR645 as an inhaled therapeutic delivered once weekly.Altair is also planning on developing a future pipeline of other best-in-class molecules for respiratory targets by exploiting the advantages of its propriety 2nd generation antisense oligonucleotide chemistry.

Transactions
Details Hidden

Design Therapeutics raised money in a private placement transaction

Details Hidden

Auspex Pharmaceuticals, Inc. issued USD Common Stock

Details Hidden

Auspex Pharmaceuticals, Inc. raised money in a private placement transaction

Investments
Details Hidden

Kalypsys, Inc. discovered and developed novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases. The firm advanced its proprietary lead program, a novel, non-corticosteroid small molecule formulated for intranasal delivery, into clinical proof of concept studies. The company was founded by Pratik Shah, Jeremy S. Caldwell, Randall W. King, Kevin D. Lustig, Peter G. Schultz and Robert Downs in 2001 and was headquartered in Solana Beach, CA.

Details Hidden

NephRx Corp. provides therapeutic products for the treatment of kidney failures. The firm's flagship product includes NX001 is a kidney growth factor peptide for acute renal failure that is currently in preclinical development for treatment of delayed graft function in transplant patients. The company was founded in 2001 by Pratik Shah and is headquartered in Kalamazoo, Michigan.

Details Hidden

Auspex Pharmaceuticals, Inc. operates as a biopharmaceutical company. The firm focuses on the development and commercialization of novel medicines for the treatment of orphan diseases. The company was founded by Sepehr Sarshar, Thomas G. Gant and Manouchehr M. Shahbaz on February 28, 2001 and is headquartered in San Diego, CA.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Pratik Shah. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Pratik Shah's profile does not indicate a business or promotional relationship of any kind between RelSci and Pratik Shah.